We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 154.21 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDM48QN TIDM0Y7T
RNS Number : 7095X
Morgan Stanley & Co. Int'l plc
20 December 2019
AMENDMENT Section (2a)
FORM 38.5
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
1. KEY INFORMATION Name of exempt market-maker Morgan Stanley & Co. International plc Company dealt in ALLERGAN PLC ------------------------------------ Class of relevant security to US$0.0001 ORDINARY SHARES which the dealings being disclosed relate (Note 1) ------------------------------------ Date of dealing 18 DECEMBER 2019 ------------------------------------ 2. DEALINGS (Note 2) (a) Purchases and sales Total number of relevant Highest price paid Lowest price paid (Note secuities accquired (Note 3) 3) 20,154 190.3505 USD 190.3400 USD ------------------- ------------------------ Total number of relevant Highest price paid Lowest price paid (Note secuities disposed (Note 3) 3) 20,154 190.3505 USD 190.3400 USD ------------------- ------------------------ (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant Price per unit e.g. CFD (Note 4) securities (Note 5) N/A N/A N/A N/A ---------------------- ------------------- --------------- (c) Options transactions in respect of existing relevant securities i) Writing, selling, purchasing or varying Product Writing, Number Exercise Type, e.g Expiry Option name, eg selling, of securities Price American, Date money paid/received call option purchasing, to which European per unit varying the option etc (Note 3) etc relates (Note 5) N/A N/A N/A N/A N/A N/A N/A ------------- --------------- --------- ----------- ------- ---------------------
(ii) Exercising
Product name, eg call Number of securities Exercise price per option unit (Note 3) N/A N/A N/A --------------------- -------------------
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Date of disclosure 20 DECEMBER 2019 Contact Name Craig Horsley ----------------- Telephone Number +44(141) 245 7736 ----------------- Name of offeree/offeror with ABBVIE INC. which connected ----------------- Nature of connection (Note 6) Advisory -----------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEPGGUAPUPBGCU
(END) Dow Jones Newswires
December 20, 2019 09:52 ET (14:52 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions